Goldberg, Manijeh http://orcid.org/0000-0002-6134-8161
Manzi, Aaron
Birdi, Amritpreet
Laporte, Brandon
Conway, Peter
Cantin, Stefanie
Mishra, Vasudha
Singh, Alka
Pearson, Alexander T. http://orcid.org/0000-0003-2801-7456
Goldberg, Eric R.
Goldberger, Sam
Flaum, Benjamin
Hasina, Rifat
London, Nyall R.
Gallia, Gary L.
Bettegowda, Chetan http://orcid.org/0000-0001-9991-7123
Young, Simon
Sandulache, Vlad
Melville, James
Shum, Jonathan
O’Neill, Sonya E.
Aydin, Erkin http://orcid.org/0000-0001-7811-2959
Zhavoronkov, Alex http://orcid.org/0000-0001-7067-8966
Vidal, Anxo http://orcid.org/0000-0002-0866-4202
Soto, Atenea
Alonso, Maria Jose
Rosenberg, Ari J.
Lingen, Mark W.
D’Cruz, Anil
Agrawal, Nishant http://orcid.org/0000-0002-1361-3231
Izumchenko, Evgeny http://orcid.org/0000-0003-3500-5664
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R43 DE023725, R44 CA192875)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
National Science Foundation (NSF IIP-1315084)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (R01 FD006325)
Article History
Received: 5 February 2022
Accepted: 6 July 2022
First Online: 17 August 2022
Change Date: 21 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-35449-1
Competing interests
: M.G., A.M., A.B., B.L., P.C., S.C., B.F. and E.R.G. are affiliated with Privo Technologies. N.A. and S.G. serve as advisors for Privo Technologies. The remaining authors declare no competing interests.